AWK vs CPRX · P/E 22, rev $4.65B vs P/E 18, rev $491.7M
American Water Works (AWK) versus Catalyst Pharmaceuticals Inc (CPRX) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the AWK and CPRX stock pages for the full models.
Not investment advice.